 |
Previous Article | Next Article 
The Journal of Neuroscience, October 1, 2002, 22(19):8586-8596
A Novel Mechanism of Dendritic Spine Plasticity Involving
Estradiol Induction of Prostaglandin-E2
Stuart K.
Amateau1 and
Margaret M.
McCarthy1, 2
1 Program in Neuroscience and 2 Department
of Physiology, University of Maryland at Baltimore, School of Medicine,
Baltimore, Maryland 21201
 |
ABSTRACT |
The mechanisms establishing and maintaining dendritic spines in the
mammalian CNS remain primarily unknown. We report a novel mechanism of neuronal spine plasticity in the developing preoptic area
in which estradiol induces prostaglandin-E2
(PGE2) synthesis that in turn increases the density
of spine-like processes. Estradiol requires PGE2 synthesis,
in vivo and in vitro, and upregulates the
dendritic spine protein spinophilin, an effect attenuated by antagonism
of the AMPA-kainate receptor. This signaling pathway may involve cross
talk between neighboring neurons and astrocytes and appears specific to
the preoptic area in that hippocampal neurons responded with an
increase in spinophilin to estradiol but not PGE2.
Regionally specific mechanisms of estradiol-mediated synaptic
plasticity allow for epigenetic control of complex sex-typic behaviors.
Key words:
estrogen; prostaglandin-E2; dendritic
spines; preoptic area; astrocytes; cyclooxygenase-2
 |
INTRODUCTION |
A primary locus of excitatory synaptic transmission in the mammalian
CNS is the dendritic spine (Colonnier, 1968 ; Larkman, 1991 ; Sorra and
Harris, 2000 ). These protrusions from dendritic shafts exhibit dynamic
changes in number, size, and shape in response to variation in hormonal
status, developmental stage, and changes in afferent input (Fifkova,
1985 ; Munoz-Cueto et al., 1991 ; Woolley and McEwen, 1992 ; Moser et al.,
1994 ; Murphy and Segal, 1996 ; McEwen and Alves, 1999 ). Understanding
the mechanisms determining the formation and plasticity of dendritic
spines remains a major goal of neuroscience.
Estradiol (E2) has proven a potent regulator of
dendritic spines and synapses in several discrete loci within the
developing and adult brain. Exposure to E2 during
a critical developmental period orchestrates permanent sexually
dimorphic synaptic patterning in regions of the hypothalamus (Matsumoto
and Arai, 1980 , 1986 ; Matsumoto et al., 1988 ; Perez et al., 1990 ; Pozzo
Miller and Aoki, 1991 ), whereas postpubertal E2
exposure controls dynamic changes in spine density in the hippocampus
(Woolley et al., 1990 ; Woolley and McEwen, 1992 ; Woolley, 1998 ) and
hypothalamus (Calizo and Flanagan-Cato, 2000 ). Elucidating the cellular
and molecular mechanisms underlying E2 regulation
of dendritic spine density provides a valuable model for establishing a
relationship between modifications in synaptic patterning and complex behaviors.
Estradiol increases the level of prostaglandin-E2
(PGE2) in such diverse tissues as kidney and
brain (Katayama and Lee, 1985 ; Ma et al., 1997 ). Elevated
PGE2 is positively correlated with inflammatory
pain responses (Ito et al., 2001 ), induction of neuronal apoptosis
after ischemic injury (Takadera et al., 2002 ), and increased tumorigenic and metastatic potential in estrogen-dependent breast cancers (Karmali et al., 1983 ; Kundu et al., 2001 ). The synthesis of
prostanoids begins with the oxygenative cyclization of arachidonic acid
by cyclooxygenase. The inducible isoform of cyclooxygenase, cyclooxygenase-2 (COX-2), is an immediate early gene enriched within
dendritic spines and postulated to play a role in synaptic plasticity
(Kaufmann et al., 1997 ). Cyclooxygenase-2 expression is strongly
regulated during normal postnatal development in the rat, following
well known histiogenetic gradients and coinciding with the critical
period for activity-dependent synaptic remodeling (Kaufmann et al.,
1996 ). Of the prostanoids synthesized by COX-2, PGE2 is one of the most biologically active of
the family and has long been recognized as a diffusible factor capable
of regulating several second messenger pathways in a variety of tissues
(Villani et al., 1974 ; Luczak et al., 1979 ; Ruwe and Myers, 1979 ).
Astrocytes are important in synapse formation and efficacy (Pfrieger
and Barres, 1997 ; Ullian et al., 2001 ), including that of
E2-induced dendritic spine synapses (Mong et al.,
1999 , 2001 ). Recent and emerging evidence implicates
PGE2 as a mediator of dynamic cell-to-cell
communication involving cross talk between astrocytes and neurons (Ma
et al., 1997 ; Rage et al., 1997 ; Bezzi et al., 1998 ; Sanzgiri et al.,
1999 ). Astrocyte-to-neuron signaling regulates the number of dendritic
spines available for synaptogenesis in regions of the developing brain
(Baloyannis and Kim, 1979 ; Meshul and Seil, 1988 ; Seil et al., 1992 ;
Seil, 1997 ). Astrocytes release glutamate in response to
PGE2 (Nicol et al., 1992 ; Bezzi et al., 1998 ),
which can activate the glutamate receptors of neighboring neurons and
modulate their dendritic spine density (McKinney et al.,
1999a ,b ; Luthi et al., 2001 ). A relationship between
PGE2 and neuronal morphology, however, has not
previously been demonstrated. We report here a novel role for
PGE2 in synaptic plasticity, the induction of
dendritic spines in response to the gonadal steroid E2. This effect is region specific in that it is
observed in the preoptic area (POA) but not the hippocampus, and it is
dependent on the activation of AMPA-kainate receptors by glutamate
that may originate from astrocytes.
 |
MATERIALS AND METHODS |
Animals. Female Sprague Dawley rats (Charles River
Laboratories, Wilmington, MA) were mated in our animal facility, and
pregnancy was confirmed by vaginal smear. Pregnant females were
isolated and allowed to deliver normally. Animals were maintained on a reverse 12 hr light/dark cycle and provided ad libitum
access to food and water. Cages were checked regularly for the presence of pups to determine the day of birth [postnatal day 0 (P0)], and
litters that were found the morning of delivery were used for
experiments. Female pups were used for experiments involving hormonal
manipulation to avoid the endogenous hormonal exposure that occurs in males.
Microdissection and culture conditions. Under sterile
conditions, brains were removed within 1-2 hr after birth, placed in a
Zivic Miller brain mold, and sectioned at 1 mm. The POA and rostral
hippocampal formation (including the rostral portions of the
differentiating CA1 and CA3 fields as well as the dentate gyrus) were
microdissected using the guidelines illustrated in Figure
1, A and B.
Briefly, the optic chiasm appears near the rostral portion of the
diencephalon and was used as a landmark to guide the rostral-to-caudal
dissection within the brain mold. The POA was then microdissected from
the 1-mm-thick section using the perimeter of the anterior commissure
for both the dorsal and lateral incisions (Fig. 1B).
Another 1 mm slice was taken immediately posterior to the section
containing the POA. This segment contained the rostral portion of the
hippocampal formation, which was microdissected using the lateral
ventricle to delineate the lateral limits, the corpus callosum, the
dorsal limit, and the dorsal portion of the third ventricle the ventral
limit (Fig. 1A). Tissue chunks were placed in HBSS+
[HBSS, HEPES buffer, antibiotic/antimycotic (10,000 U of
penicillin G sodium, 10,000 µg of streptomycin sulfate, and 25 µg
of Amphotericin B)] (Invitrogen, Grand Island, NY) and 0.25% trypsin. After 15 min at 37°C, 1 ml of 10% dextran-treated
charcoal-stripped fetal bovine serum (Invitrogen) and 0.5 ml of
antibiotic/antimycotic (FBS+) was added to deactivate the trypsin. The
solution was dissociated by mechanical triturating and centrifuged at
1000 rpm for 5 min, the supernatant was discarded, and the pellet was
resuspended in phenol red-free, sterile culture medium (SCM) [DMEM-F12
(Invitrogen) and FBS+]. Density was established, and cells were seeded
onto poly-L-lysine (MW 70,000; Sigma, St. Louis,
MO)-coated glass coverslips (number 1, 25 mm diameter; Fisher
Scientific, Pittsburgh, PA) at a density of 150,000. Plates were
maintained in an incubator at 37°C and 5% CO2
for 4 d in vitro (DIV; time of plating, DIV0). Cells
were allowed to acclimate for 24 hr before first treatment and were
treated on DIV1 and DIV2 and collected in lysis buffer on DIV3 for
Western analysis, ~24 hr after the second treatment. Treatments were
added to existing culture medium, and depending on the specific
experiment, cells were exposed to the following either individually or
in combination: (1) sesame oil vehicle, (2) 0.5 nM PGE2 in 0.9% saline,
(3) 0.5 nM PGF2 in 0.9%
saline, (4) 5 nM estradiol benzoate
(E2) in 0.001% DMSO in sesame oil, (5) 1 µM indomethacin in sesame oil, (6) 10 µM L-glutamic acid in
0.9% saline, (7) 40 µM (+)-MK801 in 0.9%
saline, (8) 100 µM DL-AP-5 in 0.9% saline, and (9) 40 µM DNQX in 0.9% saline (n = 6/group for all culture experiments). Doses of the
PGE2 and estradiol were based on published
literature (Whalen and Nadler, 1963 ; Morimoto et al., 1991 ; Mouihate
and Lestage, 1995 ; Caggiano and Kraig, 1998 ; Southall and Vasko, 2000 )
as well as our own experience (Mong et al., 1999 ). Doses of estradiol
were 5 nM in vitro and 100 µg
in vivo. This seemingly large in vivo dose was
used to overwhelm -fetoprotein, an endogenous steroid-binding
globulin found in the fetal circulation. This protein binds estradiol, preventing the hormone from crossing the blood-brain barrier and from
entering cells, thereby protecting the female fetuses from being
masculinized by estradiol originating in the dam. Levels of
-fetoprotein reach a maximum during the same perinatal period that
testosterone surges and remain at significant levels in the bloodstream
of pups for several days after birth (Montano et al., 1995 ).

View larger version (41K):
[in this window]
[in a new window]
|
Figure 1.
Microdissection of the preoptic area and the
rostral hippocampal formation. A, Sagittal drawing of
the developing rat brain demonstrating the areas collected
(shaded regions) and the landmarks used to guide
the microdissection, including the anterior commissure
(ac) and the optic chiasm (ox) for the
preoptic area (POA), and the corpus callosum and the
dorsal portion of the third ventricle (d3v) for the
hippocampal formation (hf). B,
Coronal drawing of the neonatal brain at the level of the POA.
Top left, Three-dimensional reconstruction of the
neonatal brain at the level of the section (taken from Altman and
Bayer, 1995 ). Top right, Sagittal view of the
neonatal brain displaying the rostral to caudal coordinates used for
collecting the POA. Shaded region represents the area
collected for microdissections that were guided by the anterior
commissure and the optic chiasm. cc, Corpus callosum;
BST, bed nucleus of the stria terminalis;
3v, third ventricle. Grid scale, 0.5 mm.
|
|
Immunocytochemistry: microtubule-associated protein-2 and
spinophilin immunoreactivity. Coverslips with adhered cells were immersed in 4% paraformaldehyde and 5% sucrose in 0.1 M PBS, pH 7.5, warmed to 37°C for 10 min,
washed three times in PBS, and permeabilized with 50% ethanol
for 60 min at 4°C. The cells were then washed three times in PBS and
incubated in 10% normal goat serum in 0.4% Triton X-100 PBS (PBST)
for 60 min at room temperature with agitation. After blocking, either a
mouse monoclonal anti-microtubule-associated protein-2 (MAP-2) primary
antibody (Sigma) (1:3000) or a rabbit polyclonal
anti-spinophilin/neurabin II primary antibody (Upstate Biotechnology,
Lake Placid, NY) (1:8000) was applied in 10% normal goat serum
PBST, and the cultures were incubated overnight at 4°C. The
coverslips were washed three times in PBST and incubated in
biotinylated secondary antibody (1:500; goat anti-mouse or goat
anti-rabbit; Vector Laboratories, Burlingame, CA) for 60 min at room
temperature with agitation, followed by three washes in PBST. The
cultures were then incubated with an avidin-biotin horseradish-peroxidase complex (Vectastain ABC, Elite Kit; Vector Laboratories) for 60 min at room temperature, washed twice with PBST,
and visualized with 0.05% 3,3'-diaminobenzidine tertrahydrochloride (Polysciences, Warrington, PA) and 0.005%
H2O2. After visualization, the coverslips were mounted on 2% gelatin-coated glass slides.
In vivo hormonal manipulations and comparison of spinophilin
levels between sexes. Female pups received two hormonal treatments 24 hr apart with the first within 6 hr of birth. Animals were assigned
to one of six treatment regiments including: (1) subcutaneous injections of 0.1 cc sesame oil, (2) subcutaneous injections of 100 µg of E2 in 0.1 cc sesame oil, (3) subcutaneous
injections of 25 µg of indomethacin and 100 µg of
E2 in 0.1 cc sesame oil, (4)
intracerebroventricular injections of 2 µg of
PGE2 in 0.1 cc of 0.9% saline and subcutaneous
injections of 0.1 cc oil, (5) intracerebroventricular injections of 2 µg of PGE2 in 0.1 cc of 0.9% saline and
subcutaneous injections of 25 µg indomethacin in 0.1 cc sesame oil,
or (6) intracerebroventricular injections of 0.9% saline and
subcutaneous injections of 0.1 cc sesame oil (n = 4/group). Intracerebroventricular injections were performed by hand on
cold-anesthetized pups. Under bright light, the cranial landmark Bregma
is visible through the skin and was used to locate the lateral
ventricles. Injections were performed by penetrating the skin and skull
with a 23 gauge 1 cc Hamilton syringe stereotaxically lowered to a
predetermined depth. Infusion volume was 0.1 cc and extended for a 60 sec period. Brains were collected on P2, ~24 hr after the second
treatment. To determine the levels of spinophilin within the POA on the
day of birth, POA tissue was collected within 2 hr of birth from male
(n = 5) and female (n = 5) littermates and immediately flash frozen in isopentane and stored at 70°C.
Western immunoblots. For cultured cells, coverslips were
rinsed with 250 µl of TBS and then immersed in 75 µl of lysis
buffer, pH 7.5, consisting of 0.8% Tris-HCl, 0.9% NaCl, 1% Tergitol
NP-40 (Sigma), 1 mM phenylmethylsulfonyl
fluoride, and peptidases including leupeptin, aprotinin, and pepstatin
(1 µg/ml) for 5 min at 4°C. The coverslips were grazed with a cell
scraper, and the resulting homogenate was collected. For analysis of
in vivo brain tissue, the POA and rostral hippocampal
formation were microdissected as described above, flash frozen in
isopentane, and stored at 70°C until being homogenized in
lysis buffer as described above with 0.5% Triton X-100 (Sigma)
substituting for NP-40. The homogenate was then subjected to a Bradford
protein assay to determine and standardize protein levels in subsequent
Western analyses. Protein (10 µg) was electrophoresed in separate
lanes on an 8-16% precast SDS-polyacrylamide gel (Novex, San Diego,
CA) and transferred to a polyvinyl difluoride membrane (Bio-Rad,
Hercules, CA). Membranes were blocked in 5% nonfat milk in 0.1% Tween
TBS (M-TTBS) for 1 hr at room temperature and then incubated in
anti-spinophilin/neurabin II rabbit polyclonal IgG (Upstate
Biotechnology) at 1 µg/ml in M-TTBS. A 30 min incubation of a goat
anti-rabbit HRP (New England BioLabs, Beverly, MA) conjugated IgG at a
1:10,000 dilution followed. The Phototope chemiluminescence system (New
England BioLabs) was used for detection of the protein recognized by
the antisera. The blots were exposed on Hyperfilm-ECL (Amersham,
Arlington Heights, IL) for varying exposure times (30-60 sec). The
protein was detected as a band of relative molecular mass of 120 kDa,
and the integrative grayscale pixel area-density (iad) was captured
with a CCD camera and quantified using NIH Image software.
Reverse transcription-PCR. Brains were removed and placed in
a Zivic Miller brain mold and immediately sectioned at 1 mm. The POA
was microdissected as described above, flash frozen in isopentane, and
stored at 70°C until being homogenized. Tissue from the kidney was
also collected to verify the detection of EP4. Tissue was used for
isolation of total RNA using an RNeasy Mini Kit (Qiagen, Valencia, CA).
RNA concentration was determined by spectrophotometery, and 1 µg of
RNA was reverse translated to DNA and then amplified using the one step
protocol for Ready-To-Go RT-PCR beads (Amersham Pharmacia Biotech,
Buckinghamshire, UK). DEPC-treated water and 20 pmol of each primer was
added to the RNA and RT-PCR bead at 4°C. This solution was
transferred to the thermal cycler and cycled 35 times at annealing
temperatures appropriate for each primer pair (55-62°C). All
oligonucleotides used were synthesized by Invitrogen (Rockville,
MD) with standard purity. Subsequent PCR product was electrophoresed on
a 2% agarose gel in Tris-acetate, and DNA product was visualized with
chelation of 0.5% ethidium bromide.
Gas chromatography-mass spectrometry. Female pups received
two treatments 24 hr apart with the first within 6 hr of birth. Females
were assigned to one of two regimes: two subcutaneous injections of 0.1 cc sesame oil (n = 5) or two subcutaneous injections of
100 µg of E2 in 0.1 cc sesame oil
(n = 6). The POA was collected and immediately prepared
for mass spectrophotometery 12 hr after the second treatment. Briefly,
each sample, consisting of ~30 mg of tissue, was rinsed with HBSS
(containing 138 nM NaCl, 5 mM KCl, 4 mM
NaHCO3, 5.6 mM
D-glucose, 0.3 mM
NaHPO4, and 0.3 mM
KH2PO4; Invitrogen) and
manually homogenized in a glass-microhomogenizer with 75 µl of HBSS
containing 1 mM CaCl2. An
additional 75 µl of HBSS was added, and the solution was sonicated
for 20 sec. Any tissue debris was removed by centrifugation at 12,000 rpm for 15 sec. Ten microliters of the supernatant was used for
Bradford protein assay. Fifty microliters of denatured prostanoid
standards and 250 µl of acetone were added, and the solution was
vortexed and centrifuged for 5 min. The supernatant was divided equally and dried under a steady stream of nitrogen gas. Once completely dry,
25 µl of 2% 0-methoxylamine HCl in pyridine was added to each sample. The pyridine solvent evaporated under a nitrogen stream,
and the residue in each vial was treated with reagents to synthesize
the pentafluorobenzyl ester-trimethylsilyl ether derivatives of the
prostanoids for gas chromatography-mass spectrometric (GC-MS)
analysis at the Asthma and Allergy Center of Johns Hopkins University
School of Medicine (Baltimore, MD). Levels of prostanoids were
subsequently normalized to the amount of protein in each sample.
Data collection and analyses. Analysis of MAP-2
immunocytochemical cellular morphology was performed under a Nikon
100× oil-immersion objective using the Neurolucida system
(MicroBrightField Inc., Colchester, VT). Ten neurons from six
coverslips of each treatment (n = 6/group) were
examined. Criteria for cell selection included the ability of the
experimenter to discern individual neurons stained evenly from soma to
distal processes. Neurons entangled with one another were therefore
excluded. Neurons were chosen from areas of even cell survival, thus
neurons growing within dense or sparse pockets were also excluded. The
experimenter was blind to the treatment group throughout analysis. The
following morphological features were measured: somal area (in square
micrometers), neurite length (in micrometers), neurite number, primary
and secondary neurite branching, number of spine-like processes (per
neurite), and density of spine-like processes (spine number per
micrometer), with a spine defined as any protrusion <5 µm. Analyses
of the spine-like processes incorporated the complete neurite from soma to distal end and included all processes extending from each neuron examined. Typically a 1:2 ratio of neurons to astrocytes was observed in these 3-d-old cultures. Western blots were compared within each gel,
with the exception of the in vitro spinophilin experiments where results were across several immunoblots with an n
value of two or four for each group within each blot. For these, bands were quantified as a ratio of iad with the iad of the DMSO controls of
the same gel serving as the comparison group. This standardization allowed for the analysis of multiple groups (each with an
n = 6) across multiple films. For the comparison
between sexes on the day of birth, males were compared with females on
the same gel and represented in arbitrary units. All results except
those of the GC-MS and sex dimorphism experiments were analyzed using a one-way ANOVA followed by the Student-Neumann-Keuls
post hoc multiple comparison test to determine significance
between groups. Results of the GC-MS were analyzed using Student's
t test between treatment groups, as were those of the sex
dimorphism experiment, data from which were expressed in arbitrary
units. All statistical tests used <0.05 as the criterion for significance.
GenBank accession numbers. The accession numbers for the
sequences of the previously identified
prostaglandin-E2 receptor subtypes are as
follows: EP1 (D88751); EP2 (U94708); EP3 (NM-012704); and EP4
(U94709).
 |
RESULTS |
Estradiol or PGE2 increase spine-like processes in
cultured POA neurons
To explore the possible role of E2 in
mediating changes in the morphology of neurons, POA tissue from newborn
females was dispersed and plated. Cells acclimated for 24 hr and were
then exposed to physiologic levels of E2 (5 nM) for 48 hr before postfixing and immunocytochemical
detection of neuron-specific MAP-2. Cell morphology was assessed at the
light level using the Neurolucida image analysis system.
Estradiol-treated cultures showed an almost threefold increase in the
mean number per neurite (F(3,12) = 21.8; p < 0.001), and in a separate experiment,
density (F(5,24) = 26.2; p < 0.001) of spine-like processes, with a spine
defined as any neurite protrusion <5 µm in length (Fig.
2A-D).

View larger version (47K):
[in this window]
[in a new window]
|
Figure 2.
E2 or PGE2 increase
spine-like processes of preoptic area neurons in vitro.
A, Representative photomicrograph of cultured neurons treated
with 0.5 nM PGE2 on DIV1 and DIV2 and
visualized on DIV3 after immunocytochemical detection of MAP-2.
Numerous aspects of neuronal morphology were assessed, but the only
changes observed were in the number and density of spine-like
processes, defined as any protrusion <5 µm in length. Scale bar, 25 µm. B, Representative photomicrographs of the neurites
of cultured neurons treated with vehicle, 5 nM
E2, or 5 nM E2
coadministered with 1 µM of the cyclooxygenase
inhibitor indomethacin, and visualized after MAP-2 immunocytochemistry.
Scale bar, 5 µm. C, Treatment with E2 (5 nM) or PGE2 (0.5 nM) for
48 hr resulted in a significant increase in the number of spine-like
processes on neurites. PGF2 (0.5 nM)
had no effect compared with vehicle-treated controls (10 neurons from
each coverslip, n = 6 per group, ANOVA;
*p < 0.001 compared with PGF2 and
vehicle). D, Similar effects of E2 and
PGE2 were seen on mean spine density in a separate
experiment. The combination of E2 and PGE2 was
not different from either one alone. The induction of spine-like
processes by E2 was blocked by simultaneous administration
of indomethacin (1 µM) but had no effect on the
actions of exogenous PGE2 (10 neurons from each coverslip,
n = 6 per group, ANOVA; *p < 0.001 compared with E2 + Indo and vehicle).
|
|
Spines were visualized by immunocytochemistry for MAP-2 using
diaminobenzidine as the chromagen. Microtubule proteins, such as MAP-2,
are localized to the dendritic shaft of hippocampal neurons and are
associated with the relative stability of this structure as compared
with the plasticity of dendritic spines (Kaech et al., 2001 ). Our
ability to visualize spine-like processes on cultured POA neurons with
MAP-2 immunocytochemistry may be a result of intracellular spread of
the reaction product or may be functionally related to a process of
spine induction different from that seen in hippocampus. Moreover, the
plasticity of the dendritic architecture may vary between the two regions.
We next tested the hypothesis that PGE2 is a
mediator of E2-induced spine induction. Treatment
with PGE2 (0.5 nM) for 48 hr precisely mimicked the effect of E2, causing a
significant increase in both spine number per neurite
(p < 0.001) and density
(p < 0.001). PGF2 , a
biologically active eicosanoid converted from the same immediate
precursor as PGE2, had no effect on spine number.
Simultaneous administration of the cyclooxygenase inhibitor, indomethacin (1 µM), blocked the induction of
spine-like processes by E2 but had no effect on
the actions of exogenous PGE2
(p < 0.001 from vehicle and
E2 and indomethacin). The combination of E2 and PGE2 was not
significantly different from either one alone. There were also no
significant differences between E2-treated and
control cultures in somal size, neurite length, neurite number, or
neurite branching. Similarly, the effects of PGE2
treatment were limited solely to changes in spines, with no other
effects on neuronal morphology observed (data not shown).
Estradiol or PGE2 increase spinophilin
expression in cultured POA neurons
Spinophilin, a protein highly enriched within dendritic spines,
has been implicated in regulating spine formation and function (Allen
et al., 1997 ; Feng et al., 2000 ). We therefore used it as a protein
marker of spines (Fig. 3A,B),
with the assumption that increases in spinophilin expression would
result in proportional increases in spine density. POA cell cultures
were treated as above, the cells collected and protein levels analyzed
by Western blot. Consistent with our morphological analysis, both
E2 or PGE2 induced a
threefold increase in spinophilin expression
(F(6,35) = 66.9; p < 0.001). Indomethacin again blocked the effect of
E2 but did not alter the effect of exogenous
PGE2. As with spine-like processes, the
combination of E2 and PGE2
did not increase spinophilin expression above that seen with either
treatment alone (Fig. 3C,D). Although there was a striking
similarity in the magnitude and direction of treatment effects on
spinophilin levels detected by Western blot and spine-like processes
detected by MAP-2 immunocytochemistry, a direct relationship between
these two variables has not been established.

View larger version (47K):
[in this window]
[in a new window]
|
Figure 3.
E2 or PGE2 increase
expression of spinophilin protein in the preoptic area in
vitro. A, Representative photomicrograph of the
neurites of cultured neurons treated with 5 nM
E2 and visualized after spinophilin immunocytochemistry.
Scale bar, 25 µm. B, Enlargement of process
encapsulated in A. Each punctum corresponds to one locus
of concentrated protein. Scale bar, 5 µm. C,
Representative Western immunoblot from treated cultures loaded onto
each lane 3 d after plating. Cultures were exposed to the
following either individually or in combination for 48 hr: (1) 0.5 nM PGE2, (2) 5 nM
E2, (3) 1 µM indomethacin, or (4)
vehicle. The blot was probed with an anti-spinophilin/neurabin II
rabbit polyclonal antibody that recognized an appropriate band at 120 kDa. D, Analysis of Western immunoblots of cultured
newborn preoptic area neurons treated for 48 hr in
vitro. Data represent a ratio of iad with the iad of the
vehicle controls of the same gel serving as the comparison group
(n = 6 per group). This standardization allowed for
the analysis of seven groups across three gels. Treatment with
E2 or PGE2 resulted in a significant increase
in expression of spinophilin. Coadministration of both did not augment
effects seen when applied individually. Indomethacin blocked the
estradiol-induced effect on spinophilin expression and had no effect
alone (ANOVA; *p < 0.001 compared with Indo,
E2 + Indo, or vehicle).
|
|
Antagonism of the AMPA-kainate receptor reduces both
E2- and PGE2-induced spinophilin expression
Localization of ionotropic glutamate receptors to dendritic
compartments allows for selective regulation of spine formation by
glutamate released from axonal growth cones, presynaptic terminals, and
neighboring astrocytes (Mattson, 1988 ; Goldin et al., 2001 ). Expression
of glutamate receptors peaks during a developmental time window within
which synaptogenesis occurs (Tremblay et al., 1988 ; Herrmann, 1996 ;
Zhang et al., 1996 ). We therefore tested the hypothesis that ionotropic
glutamate receptor activation participates in the estradiol-mediated
increases in spinophilin. Effects of glutamate (10 µM)
exposure paralleled those of E2 and
PGE2, demonstrating a threefold increase in
spinophilin expression (F(3,18) = 113.8; p < 0.001) in POA cell cultures (Fig.
4A,B). The selective
AMPA-kainate antagonist DNQX (40 µM)
attenuated estradiol-mediated increases in spinophilin expression by
56.6% and PGE2-mediated increases by 66.2%
(F(4,23) = 106.5; p < 0.001), establishing the role of glutamate subsequent to that of
E2 and the prostanoid (Fig. 4C). Both
the noncompetitive NMDA antagonist (+)-MK801 (40 µM) and the selective NMDA antagonist
DL-AP-5 (100 µM) had no
effect on induction of spinophilin by estradiol. Application of the any of the antagonists alone had no effect on baseline spinophilin expression (data not shown), further supporting an active role for
E2 in the induction of PGE2
synthesis and subsequent glutamate release.

View larger version (37K):
[in this window]
[in a new window]
|
Figure 4.
Antagonism of the AMPA-kainate receptor
attenuates E2- or PGE2-induced spinophilin
expression. A, Representative Western immunoblot from
treated POA cultures 3 d after plating. Cultures were exposed to
the following either individually or in combination for 48 hr: (1) 0.5 nM PGE2, (2) 5 nM
E2, (3) 10 µM glutamate, (4) 100 µM AP-5, (5) 40 µM MK801, (6) 40 µM DNQX, or (7) vehicle. The blot was probed with an
anti-spinophilin/neurabin II rabbit polyclonal antibody that recognized
an appropriate band at 120 kDa. B, C, Analysis of
Western immunoblots of cultured newborn preoptic area neurons treated
for 48 hr in vitro. Data represent a ratio of iad with
the iad of the vehicle controls of the same gel serving as the
comparison group (n = 6 per group). Treatment with
glutamate resulted in an increase in the expression of spinophilin
comparable with that induced by either E2 or
PGE2. Coadministration of the AMPA-kainate antagonist DNQX
significantly reduced both the E2 and
PGE2-induced increase in expression, whereas coapplication
of NMDA receptor antagonists had no effect on expression (ANOVA;
*p < 0.001 compared with vehicle;
**p < 0.001 compared with E2 + DNQX,
PGE2 + DNQX, and vehicle; ***p < 0.001 compared with E2 + AP-5, E2 + MK801, and
vehicle).
|
|
Prostaglandin receptor mRNA is expressed in the developing POA
For prostaglandins to promote dendritic spine formation early in
development, the cognate receptors must be expressed perinatally. RT-PCR was used to identify the population of prostaglandin receptors (EP) expressed in the POA on the day of birth and amplified the mRNA of
three of the four subtypes, EP1, EP2, and EP3 (Fig.
5A). EP4 mRNA was not detected
in the POA, but was amplified in kidney as a positive control.

View larger version (35K):
[in this window]
[in a new window]
|
Figure 5.
The in vitro effects of
E2 and PGE2 on spinophilin expression are
maintained in vivo. A, The mRNA for three
of the four PGE2 receptor (EP1-4) subtypes are detectable
within the POA as early as 4 hr post-utero. Tissue from rat kidney was
used as a positive control for EP4. PN0, Postnatal day 0. B, Representative Western immunoblot of tissue from the
POA collected from animals treated for 48 hr beginning on P0. Animals
were exposed to the following either individually or in combination:
(1) 0.1 cc sesame oil (subcutaneously), (2) 100 µg of E2
in 0.1 cc sesame oil (subcutaneously), (3) 25 µg of indomethacin in
0.1 cc sesame oil (subcutaneously), (4) 2 µg of PGE2 in
0.1 cc in 0.9% saline (intracerebroventricularly), or (5) 0.1 cc of
0.9% saline (intracerebroventricularly). The blot was probed with an
anti-spinophilin/neurabin II rabbit polyclonal antibody that recognized an appropriate band at 120 kDa. C, D, Quantification of Western immunoblots of
preoptic area tissue treated for 48 hr in vivo. Each
analysis represents one immunoblot quantified as a ratio of iad to that
of controls of the same gel (n = 4 per group).
Treatment with E2 or PGE2 resulted in a
significant increase in levels of spinophilin. Indomethacin blocked the
estradiol-induced effect on spinophilin, whereas its coapplication with
PGE2 had no effect (ANOVAs; *p < 0.001 compared with E2 + Indo and vehicle;
**p < 0.001 compared with vehicle).
|
|
Estradiol or PGE2 increase spinophilin expression
in vivo in the POA
We next asked whether PGE2 is required for
the induction of dendritic spines by E2 in the
POA in vivo. Newborn female rat pups received subcutaneous
injections of E2 (100 µg) or
intracerebroventricular infusions of PGE2 (2 µg). Forty-eight hours later, the brains were collected, and the POA
was rapidly dissected and flash frozen until assay by Western blot. The
expression of spinophilin was significantly increased after
E2 (F(2,9) = 23.5; p = 0.001) (Fig. 5B,C) and
PGE2 (F(2,9) = 77.6; p < 0.001) (Fig. 5D) in the
developing POA as compared with the appropriate controls. In a separate
group of animals receiving coadministration of indomethacin (25 µg, s.c.) with E2 or PGE2, the
E2-induced increase in spinophilin expression was
fully blocked (p < 0.001) (Fig.
5C,D), with no change in the effect of exogenous
PGE2.
Estradiol increases PGE2 levels in the POA
Coapplication of E2 and
PGE2 showed neither an additive nor a synergistic
response, further suggesting that these compounds are inducing spine
induction through a serial rather than parallel process (although the
possibility of a ceiling effect of each compound cannot be ruled out).
Coadministration of the prostaglandin synthesis inhibitor indomethacin
blocked the effect of E2, implying that
PGE2 acts downstream of E2.
We therefore tested the hypothesis that E2
increases PGE2, while also investigating whether
E2 promotes the synthesis of the other
metabolites of arachidonic acid. We used GC-MS analysis of POA tissue
collected from pups 36 hr after being treated immediately postpartum
with either E2 or vehicle. The homogenate was
evaluated for differences in the arachidonic acid metabolites
PGD2, PGE2,
PGF2 , and the two nonenzymatic byproducts of
prostacyclin (PGI2), and
thromboxane-A2 (TXA2), 6-keto-PGF1 and TXB2,
respectively. Of the lipids analyzed, only PGE2
showed a significant difference (p < 0.002)
with a threefold increase from ~70 pg/mg of protein to ~280 pg/mg
of protein after exposure to E2 (Fig.
6). Two of the five control animals had
PGE2 levels so low as to be undetectable above
background and were scored as zero. Whereas PGD2,
PGF2 , and 6-keto-PGF1 levels were significantly greater than that of
PGE2, no differences were found between treatment
groups. TXB2 levels were undetectable above
background (data not shown) in both groups.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 6.
E2 increases PGE2 levels
in the developing preoptic area. Quantitative GC-MS analysis was used
to measure the levels of various prostanoids and their metabolites in
the preoptic area of newborn female rats treated with E2 or
vehicle for 36 hr. A, PGE2 levels were
increased threefold in rats treated with 100 µg of E2 in
0.1 cc sesame oil (subcutaneously) (t test,
*p < 0.002). B, There was no change
in PGD2, PGF2 , or
6-keto-PGF1 . TXB2 was undetectable above
background. C, The pathway of arachidonic acid
conversion to the prostanoids via cyclooxygenase suggests the effects
of E2 may be acting directly at PGE synthase or indirectly
via COX-2.
|
|
Estradiol, but not PGE2, increases
spinophilin in the rostral hippocampal formation
Dendritic spine density is markedly increased on the
pyramidal neurons of the adult hippocampus after
E2 exposure (Woolley et al., 1990 ; Woolley and
McEwen, 1992 ; Woolley, 1998 ), but this potential has not been
investigated in immature hippocampal neurons. We therefore explored the
possible involvement of both E2 and PGE2 in the induction of spines in developing
hippocampus. The rostral portion of the perinatal hippocampus was
plated and allowed to acclimate for 24 hr before exposure to either
E2 or PGE2 for 48 hr. As
compared with vehicle-treated cells, E2 but not
PGE2 induced a significant increase in
spinophilin expression (F(2,9) = 58.5;
p < 0.001) (Fig.
7A,B).
E2 also induced a significant increase in
spinophilin expression in vivo as compared with control tissue (F(2,9) = 66.9;
p < 0.001) (Fig. 7C). Unlike our
observations in the POA, however, coadministration of indomethacin with
E2 did not inhibit this increase. Furthermore,
neither PGE2 alone nor PGE2
coapplied with indomethacin had any effect on spinophilin expression in
hippocampal neurons (Fig. 7D).

View larger version (27K):
[in this window]
[in a new window]
|
Figure 7.
Different mechanisms appear involved in the
regulation of spinophilin protein in hippocampal tissue.
A, Representative Western immunoblot of tissue from the
POA collected from animals treated for 48 hr beginning on P0. Animals
were exposed to the following either individually or in combination:
(1) 0.1 cc sesame oil (subcutaneously), (2) 100 µg of E2
in 0.1 cc sesame oil (subcutaneously), (3) 25 µg of indomethacin in
0.1 cc sesame oil (subcutaneously), (4) 2 µg of PGE2 in
0.1 cc in 0.9% saline (intracerebroventricularly), or (5) 0.1 cc of
0.9% saline (intracerebroventricularly). The blot was probed with an
anti-spinophilin/neurabin II rabbit polyclonal antibody that recognized
an appropriate band at 120 kDa. B, Analysis of Western
immunoblots from cultured newborn rostral hippocampal tissue treated
for 48 hr in vitro. The analysis represents one
immunoblot quantified as a ratio of iad to that of controls of the
same gel (n = 4 per group). Treatment
with E2 (5 nM) but not PGE2 (0.5 nM) resulted in a significant increase in expression of
spinophilin (ANOVA; *p < 0.001 compared with
PGE2 or vehicle). C, D, Quantification of
Western immunoblots from animals treated 48 hr in vivo
as described in A. Each analysis represents one immunoblot
quantified as a ratio of iad to that of controls of the same gel
(n = 4 per group). Treatment with E2
alone or in combination with indomethacin resulted in a significant
increase in expression of spinophilin. PGE2 alone or in
combination with indomethacin had no effect on spinophilin expression
(ANOVA; **p < 0.001 compared with vehicle).
|
|
Males exhibit greater spinophilin protein
levels on the day of birth in the POA
To investigate the possibility of a sexually dimorphic expression
of spinophilin in the developing POA, tissue was collected within 2 hr
of birth from male and female littermates and analyzed by Western blot.
Males had two and a half times the level of spinophilin protein in the
POA as that of females (t test, p < 0.001)
(Fig. 8). The magnitude of this sex
difference is consistent with the effects on spinophilin levels induced
by estradiol and PGE2 treatment both in
vivo and in vitro and suggests that the naturally
occurring sex difference in spinophilin is the result of higher
endogenous estradiol in the newborn male POA.

View larger version (44K):
[in this window]
[in a new window]
|
Figure 8.
Sexually dimorphic expression of spinophilin on
the day of birth in the POA. A, Western immunoblot of
preoptic area tissue collected from males and females on the day of
birth. The blot was probed with an anti-spinophilin/neurabin II rabbit
polyclonal antibody that recognized an appropriate band at 120 kDa.
B, Quantification of the above Western immunoblot of
male and female preoptic area tissue. We determined iad for each band
in arbitrary units, and males were compared to females on the same gel
(n = 5/group). Males displayed two and a half times
the level of spinophilin protein in the POA as compared with that of
females (t test, *p < 0.001). The
magnitude of difference is consistent with the effects on spinophilin
levels induced by estradiol or PGE2 treatment both
in vivo and in vitro.
|
|
 |
DISCUSSION |
We report here a novel mechanism for induction of dendritic spines
completely dependent on E2-induced increases in
the prostanoid, PGE2, and subsequent
glutamatergic activation of AMPA-kainate receptors. Cultured POA
neurons exposed to either E2 or
PGE2 exhibited an almost threefold rise in the
number and density of spine-like processes. The effects of
E2 were blocked by the prostanoid synthesis inhibitor, indomethacin, and the combination of
E2 and PGE2 was equally
effective as either one alone. The related but distinct prostaglandin,
PGF2 , had no effect on spine-like processes of
cultured preoptic neurons. Using spinophilin as a marker for spines
in vivo, we found parallel responses to those seen in
vitro. Although a ceiling effect cannot be ruled out,
coapplication of E2 and
PGE2 showed neither an additive nor a synergistic
response, suggesting that these compounds are acting through a serial
rather than parallel process. Quantitative GC-MS analysis demonstrated a threefold increase in the levels of PGE2 within
the POA of neonates exposed to E2 as compared
with vehicle-treated controls. There was no change in the levels of the
other prostanoids, suggesting the effect of E2 is
specific to PGE2. A comparison of spinophilin between the sexes found neonate males to express 2.5-fold greater levels than that of neonate females in the perinatal POA, a difference similar in magnitude to that induced by estrogen treatment of females.
Glutamatergic activation of AMPA-kainate receptors significantly increased spinophilin expression, and antagonism of these receptors significantly reduced both the E2 and
PGE2-induced increases in protein expression.
Finally, the ability of E2 to induce spinophilin was also observed in hippocampal neurons, however these effects appear
to be mediated through a mechanism not involving
PGE2.
In rodents, the newborn brain is essentially bipotential, equally
capable of becoming masculinized or feminized. Resolution of the
ultimate phenotype is a function of the hormonal milieu established by
the gonads. In males, the neonatal testes secrete a copious quantity of
testosterone during a restricted perinatal developmental window. This
testosterone gains access to the brain where it is converted locally to
E2 by neuronal aromatase (Naftolin et al., 1971 ;
Ryan et al., 1972 ; MacLusky and Naftolin, 1981 ). As a result, local
levels of E2 in the developing hypothalamus can
be as high as 5 ng/gm brain tissue (Rhoda et al., 1984 ). Estradiol induces permanent effects on the developing neuronal substrate, most
notably the establishment of sexually dimorphic synaptic patterning.
The frequency of dendritic spine synapses can be twice as high in some
regions of the male brain compared with that of the female, and yet be
the exact opposite in an adjacent region (Matsumoto and Arai, 1980 ,
1986 ; Pozzo Miller and Aoki, 1991 ; Mong et al., 1999 , 2001 ). Despite
the fundamental significance of the establishment of sexually dimorphic
synaptic profiles, the mechanism or mechanisms by which
E2 achieves this end has remained virtually unknown.
The POA, a subdivision of the hypothalamus, is centrally involved in
the control of sex-typic reproductive behavior, including sexual and
maternal behaviors (Meisel and Sachs, 1994 ; Numan, 1994 ). Sex
differences in morphometry of this brain region include volumetric
variance in particular nuclei (Bloch and Gorski, 1988 ) and synaptic
patterning (Raisman and Field, 1973 ; Larriva-Sahd, 1991 ). Estrogen
receptors are highly expressed by preoptic neurons throughout life
(Fuxe et al., 1987 ; DonCarlos and Handa, 1994 ; DonCarlos, 1996 ), and
synaptic patterns of the adult brain are established by the neonatal
hormonal profile (Raisman and Field, 1973 ), although additional
plasticity is found in the female at puberty (Anderson, 1982 ). Although
we have demonstrated a role for prostaglandins in establishing the
neuroarchitecture of the developing brain, it is clear the adult POA
remains responsive to PGE2 and may involve a
recapitulation of developmental processes. Sexually unresponsive males
can be induced to copulate after POA infusions of
PGE2 (Clemens and Gladue, 1977 ), and
prostaglandins within the POA are critically involved in control of
body temperature (Adair, 1977 ; Gordon and Heath,
1980 ).
A critical but limiting variable in studies of synaptic patterning is
the ability to quantify synapses. Traditional and reliable methods
include Golgi impregnation, which allows for analysis of overall cell
morphology but not the presence of synapses, and electron microscopy,
which allows for the latter but not the former. Although highly
informative, both of these techniques are labor intensive and can
become prohibitive when multiple manipulations are compared.
Spinophilin was used here as an indirect marker for spines. Spinophilin
localizes to the head and neck region of dendritic spines and interacts
with several proteins, including actin (Stephens and Banting, 2000 ).
Actin is central to the formation, maintenance, morphology, and
activity of spines (Fifkova, 1985 ; Matus, 2000 ; Kaech et al., 2001 ),
and spinophilin bundles actin filaments, suggesting a role as one of
the organizers of the actin-based cytoskeleton in dendritic spines
(Nakanishi et al., 1997 ; Feng et al., 2000 ; Stephens and Banting,
2000 ). Such properties make spinophilin not only a marker of dendritic
spine density, but also suggest it may be a mediator of dynamic changes
in spine morphology. Others have also observed a comparable
relationship between the magnitude of synapse-related proteins and
changes in spinophilin (Brake et al., 2001 ), suggesting that this
biomarker is a valuable tool for assaying changes in synaptic profiling under a myriad of conditions. In the hippocampus we detected a 30%
increase in spinophilin expression in response to
E2, a result consistent in both scale and
direction with previous studies investigating the effects of
E2 on hippocampal spines and spine synapses
(Woolley et al., 1990 ; Woolley and McEwen, 1992 ; Woolley, 1998 ).
Although extremely powerful, using spinophilin as a marker of dendritic spines does have its limitations. Analyses of protein levels cannot discern if a treatment selectively promotes the construction of some
spines versus the dismantling of others. Furthermore, assays for
spinophilin do not reveal information regarding the status of spine
function or activity. Nonetheless, the striking correlation we observed
in the effects of treatment on spine-like processes and spinophilin
levels measured by Western blot both in vivo and in
vitro suggest this protein is a reliable predictor of spine density.
A link between glutamate receptor activation, which initiates most
changes in synaptic strength, and subsequent modifications of dendritic
density has been difficult to establish in the vertebrate CNS.
Combined electrophysiologic and morphometric analyses have demonstrated
the necessity of AMPA receptor activation in the maintenance and
structure of postsynaptic dendritic spines (McKinney et al.,
1999a ,b ). NMDA receptor activation, on the other hand, appears
critical to synaptogenesis and the pruning of dendritic spines (Luthi
et al., 2001 ). Although our investigations do not explore
synaptogenesis per se, they do demonstrate that AMPA-kainate receptor
activation is critical and sufficient to increase a dendritic protein,
spinophilin, within the developing POA in response to estradiol
exposure. Of great interest is the finding that AMPA kainate-specific antagonists alone had no effect on baseline spinophilin expression, suggesting that in the POA, glutamatergic activation of these receptors
are not involved in maintenance, but rather creation of dendritic spines.
A central question raised by the current findings is whether
E2-induced increases in
PGE2 are manifest in POA neurons, astrocytes, or
a combination of the two. Although it is clear that neurons of the POA
express significant concentrations of estrogen receptor throughout life
(Fuxe et al., 1987 ; Yuri and Kawata, 1991 ; DonCarlos, 1996 ), there is
ambiguity regarding the potential for the same receptors in astrocytes
of the POA (Langub and Watson, 1992 ; Ojeda and Ma, 1999 ). Similarly,
there is uncertainty regarding whether COX-2 is exclusively neuronal or
also present in astrocytes under restricted conditions (Kaufmann et
al., 1996 ; O'Banion et al., 1996 ). Given that the preponderance of
evidence suggests neuronal localization for both the estrogen receptor
and COX-2, we have developed a working model in which
E2 increases PGE2 in
neurons which then diffuses to act on neighboring astrocytes. Evidence suggests that neighboring astrocytes respond to
PGE2 by releasing glutamate (Nicol et al., 1992 ;
Bezzi et al., 1998 ), which in our model back-communicates to trigger
neuronal AMPA-kainate receptors, activation of which has been
implicated in dendritic spine modification (McKinney et al.,
1999a ; Goldin et al., 2001 ; Luthi et al., 2001 ). Several
components of this model remain to be tested.
Our data suggest a regionally specific effect of
E2 in the POA involving the synthesis of
PGE2 because this mechanism was not evident in
the developing hippocampus. Interestingly, outside of the cortex, the
densest collection of COX-2-expressing neurons is found in the POA,
with only a few in the CA1 field of the hippocampus (Breder et al.,
1995 ). Regional differences in either the receptors or synthetic
enzymes for PGE2 may underlie the specificity of the effects of PGE2. The localization of COX-2 to
dendritic spines and its rapid induction with synaptic activity
previously led to the hypothesis that this immediate early gene is a
modulator of neuronal plasticity (Kaufmann et al., 1997 ). The
observation that pharmacological inhibition of COX-2 does not result in
disturbances in learning and memory seemed to contradict this view
(Kaufmann et al., 1997 ). Our findings may shed light on this
discrepancy. Estradiol-induced increases in hippocampal dendritic spine
density have been correlated with enhanced NMDA-mediated currents
(Woolley and McEwen, 1994 ; Woolley et al., 1997 ) and exaggerated LTP
(Warren et al., 1995 ; Cordoba Montoya and Carrer, 1997 ; Gupta et al., 2001 ), a cellular correlate of learning and memory. Performance on
various hippocampal-dependent spatial tasks are enhanced by estradiol
pretreatment, and the increase in dendritic spines induced by estradiol
has been directly correlated with enhanced performance (Sandstrom and
Williams, 2001 ). In contrast, E2 induction of
dendritic spines in the POA is likely related to sex differences in
reproductive behavior and would be predicted to have no effect on
learning and memory. This divergence in the mechanism of
E2-mediated neuronal plasticity demonstrates how
epigenetic control of behavior is achieved through regionally specific
signal transduction pathways.
 |
FOOTNOTES |
Received April 4, 2002; revised May 30, 2002; accepted July 5, 2002.
This work was supported by a predoctoral National Research Service
Award (MH12862) to S.K.A. and a grant from the National Institutes of
Mental Health (MH52716) to M.M.M. We thank J. J. Alt for his
critical and conscientious technical assistance with culture
preparation as well as A. Z. Murphy, S. M. Thompson, A. Keller, and D. Weinreich for their constructive comments on this manuscript.
Correspondence should be addressed to Stuart K. Amateau, Program in
Neuroscience, University of Maryland at Baltimore, School of Medicine,
655 West Baltimore Street, BRB 5020, Baltimore, MD 21201. E-mail:
samat001{at}umaryland.edu.
 |
REFERENCES |
-
Adair ER
(1977)
Skin, preoptic, and core temperatures influence behavioral thermoregulation.
J Appl Physiol
42:559-564[Abstract/Free Full Text].
-
Allen PB,
Ouimet CC,
Greengard P
(1997)
Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines.
Proc Natl Acad Sci USA
941:9956-9961.
-
Altman J,
Bayer SA
(1995)
In: Atlas of prenatal rat brain development. Boca Raton, FL: CRC.
-
Anderson CH
(1982)
Changes in dendritic spine density in the preoptic area of the female rat at puberty.
Brain Res Bull
8:261-265[Medline].
-
Baloyannis SJ,
Kim SU
(1979)
Experimental modification of cerebellar development in tissue culture: x-irradiation induces granular degeneration and unattached Purkinje cell dendritic spines.
Neurosci Lett
12:283-288[ISI][Medline].
-
Bezzi P,
Carmignoto G,
Pasti L,
Vesce S,
Rossi D,
Rizzini BL,
Pozzan T,
Volterra A
(1998)
Prostaglandins stimulate calcium-dependent glutamate release in astrocytes.
Nature
391:281-285[Medline].
-
Bloch GJ,
Gorski RA
(1988)
Estrogen/progesterone treatment in adulthood affects the size of several components of the medial preoptic area in the male rat.
J Comp Neurol
4:613-622.
-
Brake WG,
Alves SE,
Dunlop JC,
Lee SJ,
Bulloch K,
Allen PB,
Greengard P,
McEwen BS
(2001)
Novel target sites for estrogen action in the dorsal hippocampus: an examination of synaptic proteins.
Endocrinology
142:1284-1289[Abstract/Free Full Text].
-
Breder CD,
Dewitt D,
Kraig RP
(1995)
Characterization of inducible cyclooxygenase in rat brain.
J Comp Neurol
355:296-315[ISI][Medline].
-
Caggiano AO,
Kraig RP
(1998)
Prostaglandin E2 and 4-aminopyridine prevent the lipopolysaccharide- induced outwardly rectifying potassium current and interleukin-1beta production in cultured rat microglia.
J Neurochem
70:2357-2368[Medline].
-
Calizo LH,
Flanagan-Cato LM
(2000)
Estrogen selectively regulates spine density within the dendritic arbor of rat ventromedial hypothalamic neurons.
J Neurosci
20:1589-1596[Abstract/Free Full Text].
-
Clemens LG,
Gladue BA
(1977)
Effect of prostaglandin E2 on masculine sexual behaviour in the rat.
J Endocrinol
75:383-389[Abstract/Free Full Text].
-
Colonnier M
(1968)
Synaptic patterns on different cell types in the different laminae of the cat visual cortex. An electron microscope study.
Brain Res
9:268-287[Medline].
-
Cordoba Montoya DA,
Carrer HF
(1997)
Estrogen facilitates induction of long term potentiation in the hippocampus of awake rats.
Brain Res
778:430-438[ISI][Medline].
-
DonCarlos LL
(1996)
Developmental profile and regulation of estrogen receptor (ER) mRNA expression in the preoptic area of prenatal rats.
Brain Res Dev Brain Res
94:224-233[Medline].
-
DonCarlos LL,
Handa RJ
(1994)
Developmental profile of estrogen receptor mRNA in the preoptic area of male and female neonatal rats.
Brain Res Dev Brain Res
79:283-289[Medline].
-
Feng J,
Yan Z,
Ferreira A,
Tomizawa K,
Liauw JA,
Zhuo M,
Allen PB,
Ouimet CC,
Greengard P
(2000)
Spinophilin regulates the formation and function of dendritic spines.
Proc Natl Acad Sci USA
97:9287-9292[Abstract/Free Full Text].
-
Fifkova E
(1985)
A possible mechanism of morphometric changes in dendritic spines induced by stimulation.
Cell Mol Neurobiol
5:47-63[ISI][Medline].
-
Fuxe K,
Cintra A,
Agnati LF,
Harfstrand A,
Wikstrom AC,
Okret S,
Zoli M,
Miller LS,
Greene JL,
Gustafsson JA
(1987)
Studies on the cellular localization and distribution of glucocorticoid receptor and estrogen receptor immunoreactivity in the central nervous system of the rat and their relationship to the monoaminergic and peptidergic neurons of the brain.
J Steroid Biochem
27:159-170[Medline].
-
Goldin M,
Segal M,
Avignone E
(2001)
Functional plasticity triggers formation and pruning of dendritic spines in cultured hippocampal networks.
J Neurosci
21:186-193[Abstract/Free Full Text].
-
Gordon CJ,
Heath JE
(1980)
Effects of prostaglandin E2 on the activity of thermosensitive and insensitive single units in the preoptic/anterior hypothalamus of unanesthetized rabbits.
Brain Res
183:113-121[ISI][Medline].
-
Gupta RR,
Sen S,
Diepenhorst LL,
Rudick CN,
Maren S
(2001)
Estrogen modulates sexually dimorphic contextual fear conditioning and hippocampal long-term potentiation (LTP) in rats(1).
Brain Res
888:356-365[ISI][Medline].
-
Herrmann K
(1996)
Differential distribution of AMPA receptors and glutamate during pre- and postnatal development in the visual cortex of ferrets.
J Comp Neurol
375:1-17[ISI][Medline].
-
Ito S,
Okuda-Ashitaka E,
Minami T
(2001)
Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin.
Neurosci Res
41:299-332[ISI][Medline].
-
Kaech S,
Parmar H,
Roelandse M,
Bornmann C,
Matus A
(2001)
Cytoskeletal microdifferentiation: a mechanism for organizing morphological plasticity in dendrites.
Proc Natl Acad Sci USA
98:7086-7092[Abstract/Free Full Text].
-
Karmali RA,
Welt S,
Thaler HT,
Lefevre F
(1983)
Prostaglandins in breast cancer: relationship to disease stage and hormone status.
Br J Cancer
48:689-696[ISI][Medline].
-
Katayama S,
Lee JB
(1985)
Estradiol stimulates rat renopapillary prostaglandin E2 (PGE2), but not PGF2 alpha biosynthesis.
Endocrinology
117:656-661[Abstract].
-
Kaufmann WE,
Worley PF,
Pegg J,
Bremer M,
Isakson P
(1996)
COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex.
Proc Natl Acad Sci USA
93:2317-2321[Abstract/Free Full Text].
-
Kaufmann WE,
Andreasson KI,
Isakson PC,
Worley PF
(1997)
Cyclooxygenases and the central nervous system.
Prostaglandins
54:601-624[ISI][Medline].
-
Kundu N,
Yang Q,
Dorsey R,
Fulton AM
(2001)
Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer.
Int J Cancer
93:681-686[ISI][Medline].
-
Langub Jr MC,
Watson Jr RE
(1992)
Estrogen receptor-immunoreactive glia, endothelia, and ependyma in guinea pig preoptic area and median eminence: electron microscopy.
Endocrinology
130:364-372[Abstract].
-
Larkman AU
(1991)
Dendritic morphology of pyramidal neurones of the visual cortex of the rat: III. Spine distributions.
J Comp Neurol
306:332-343[ISI][Medline].
-
Larriva-Sahd J
(1991)
Ultrastructural evidence of a sexual dimorphism in the neuropil of the medial preoptic nucleus of the rat: a quantitative study.
Neuroendocrinology
54:416-419[Medline].
-
Luczak A,
Szmigielski S,
Gumulka SW
(1979)
Decreased myocardial and renal content of 3', 5'-AMP in genetically hypertensive rats: effects of PGE2 and PGF2 alpha.
Pol J Pharmacol Pharm
31:589-594[Medline].
-
Luthi A,
Schwyzer L,
Mateos JM,
Gahwiler BH,
McKinney RA
(2001)
NMDA receptor activation limits the number of synaptic connections during hippocampal development.
Nat Neurosci
4:1102-1107[ISI][Medline].
-
Ma YJ,
Berg-von der Emde K,
Rage F,
Wetsel WC,
Ojeda SR
(1997)
Hypothalamic astrocytes respond to transforming growth factor-alpha with the secretion of neuroactive substances that stimulate the release of luteinizing hormone-releasing hormone.
Endocrinology
138:19-25[Abstract/Free Full Text].
-
MacLusky NJ,
Naftolin F
(1981)
Sexual differentiation of the central nervous system.
Science
2114:1294-1302.
-
Matsumoto A,
Arai Y
(1980)
Sexual dimorphism in `wiring pattern' in the hypothalamic arcuate nucleus and its modification by neonatal hormonal environment.
Brain Res
190:238-242[ISI][Medline].
-
|